Notice2023-06316
Advisory Committee on Breast Cancer in Young Women; Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
March 28, 2023
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
In accordance with regulatory provisions, the Centers for Disease Control and Prevention (CDC) announces the following meeting for the Advisory Committee on Breast Cancer in Young Women (ACBCYW). This meeting is open to the public, limited only by audio and web conference lines (150 web conference participant spaces available). Online registration is required.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 59 (Tuesday, March 28, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 59 (Tuesday, March 28, 2023)]
[Notices]
[Page 18318]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-06316]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee on Breast Cancer in Young Women; Meeting
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with regulatory provisions, the Centers for
Disease Control and Prevention (CDC) announces the following meeting
for the Advisory Committee on Breast Cancer in Young Women (ACBCYW).
This meeting is open to the public, limited only by audio and web
conference lines (150 web conference participant spaces available).
Online registration is required.
DATES: The meeting will be held on May 10, 2023, 11 a.m. to 4:30 p.m.,
EDT.
ADDRESSES: This meeting is virtual. Online Registration Required: All
ACBCYW Meeting participants must register for the meeting online at
least 2 business days in advance at <a href="https://www.cdc.gov/cancer/breast/what_cdc_is_doing/conference.htm">https://www.cdc.gov/cancer/breast/what_cdc_is_doing/conference.htm</a>. Please complete all the required
fields and submit your registration no later than May 8, 2023.
Registered participants will receive the audio and web conference
access instructions before the meeting.
FOR FURTHER INFORMATION CONTACT: Kimberly E. Smith, MBA, MHA,
Designated Federal Officer, National Center for Chronic Disease
Prevention and Health Promotion, Centers for Disease Control and
Prevention, 4770 Buford Hwy. NE, Mailstop S107-4, Atlanta, Georgia
30341, Telephone (404) 498-0073, Fax (770) 488-4760. Email:
<a href="/cdn-cgi/l/email-protection#0e6f6d6c6d77794e6d6a6d20696178"><span class="__cf_email__" data-cfemail="61000203021816210205024f060e17">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
Purpose: The Committee provides advice and guidance to the
Secretary, HHS; the Assistant Secretary for Health; and the Director,
CDC, regarding the formative research, development, implementation and
evaluation of evidence-based activities designed to prevent breast
cancer (particularly among those at heightened risk) and promote the
early detection and support of young women who develop the disease. The
advice provided by the Committee will assist in ensuring scientific
quality, timeliness, utility, and dissemination of credible appropriate
messages and resource materials.
Matters to be Considered: The agenda will include discussions on
current topics related to breast cancer in young women. These will
include Mental/Behavioral Health, Sexual Health, Genetics and Genomics,
and Provider Engagement. Agenda items are subject to change as
priorities dictate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-06316 Filed 3-27-23; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on March 28, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.